Short answer
Acadia Healthcare Company Inc (ACHC) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 operating and financial results announced for the quarter ended September 30, 2026.
Acadia Healthcare Company Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 operating and financial results announced for the quarter ended September 30, 2026
- Full results and management commentary available in Exhibit 99.1 press release
Item 7.01 · Regulation FD Disclosure
- Third-quarter 2026 results conference call scheduled for November 5, 2026 at 9:00 a.m. Eastern Time
- Investor slides in Exhibit 99.2 may contain operating and financial details not included in this section
- Key risks highlighted: Medicaid financing changes under the OBBBA, potential volume pressure and payment delays
- Debt-service capacity, labor costs, cybersecurity, regulatory actions and patient incidents remain material investor risks
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $895.3M, up 5.1%, with same-facility revenue up 5.2% on 1.1% higher patient days and 4.0% pricing growth
- Adjusted EBITDA $176.4M, up 2%, but adjusted EPS fell 17% to $0.60 as reported net income declined 5% to $34.5M
- Acute revenue rose 11.3% and volumes 7.5%, offset by Specialty revenue down 8.2% and CTC revenue down 2.3%
- 2026 guidance raised: revenue $3.44-$3.46B, adjusted EBITDA $615-$625M, adjusted EPS $1.70-$1.80
- Added 220 licensed beds, while management expects approximately $60M incremental 2027 EBITDA from facilities opened over the last four years
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Acadia Healthcare Company Inc 8-K filings
Get the next ACHC 8-K as it lands
Follow ACHC for push alerts, or ask the research agent what this filing means.